ICSA-15-132-01

icsaUScisa_csaf_ot

Hospira LifeCare PCA Infusion System Vulnerabilities

view advisory published 2015-02-12

This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

01

describes (1)

Related CVEs.

IDseverity exploitable
CVE-2015-1012UShigh7.5OT elevated—
Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicate…
02

references

External citations — patches, advisories, analysis.

03

remediations (1)

  • MitigationLifeCare PCA Infusion System

    CS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002. ICS-CERT encourages asset owners to take defensive measures to protect against this and other cybersecurity risks.

scry

Advisories like this name the exposed products attackers go after on your perimeter. See what is exposed on your perimeter with a free passive scan.

Free scan